This trial is active, not recruiting.

Conditions metabolic syndrome, syndrome x, mets,, diabetes mellitus, non-insulin-dependent
Sponsor Asklepios proresearch
Collaborator City of Hamburg
Start date November 2008
End date May 2020
Trial size 1962 participants
Trial identifier NCT01313156, AKS#1833


Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Metabolic Syndrome, Type 2 Diabetes
time frame: 10 years

Eligibility Criteria

Male or female participants from 25 years up to 60 years old.

Inclusion Criteria: - 25-60 years men and women willing to give consent Exclusion Criteria: - diabetes (type 1 or 2)

Additional Information

Official title Lipids and Glucose Under Prospective Surveillance
Principal investigator Dirk Mueller-Wieland, Prof., MD
Description The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers, anthropometrics, dietary habits, physical activity, perceived stress along with genetic information from "healthy workers" (25-60years) to better understand phenotype-genotype associations leading to MetS and type 2 diabetes.
Trial information was received from ClinicalTrials.gov and was last updated in March 2011.
Information provided to ClinicalTrials.gov by Asklepios proresearch.